Management of the N0 neck in early cancer of the oral tongue

Clin Otolaryngol Allied Sci. 1999 Feb;24(1):75-9. doi: 10.1046/j.1365-2273.1999.00224.x.

Abstract

Elective treatment of the clinically negative neck in the management of early oral tongue cancers remains controversial. A retrospective review of 71 patients with T1, 2 N0M0 squamous cell carcinoma of the oral tongue treated at the Royal Marsden Hospital was carried out. Cervical nodal recurrence at 2 years was 17% in the group of patients who received elective neck treatment as compared to 43% in the group who had observation of the neck and the difference is statistically significant (P = 0.025). The difference in 5-year survival between the group who had elective neck treatment and the group who did not (75% versus 65%) was not statistically significant. Until future research allows us to be more selective on the basis of a reliable panel of histological and/or biological markers for propensity to nodal metastases, elective neck treatment should be considered in the initial management of the patients with early oral tongue cancer.

MeSH terms

  • Carcinoma, Squamous Cell / secondary
  • Carcinoma, Squamous Cell / therapy*
  • Combined Modality Therapy
  • Female
  • Glossectomy
  • Humans
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neck
  • Neck Dissection
  • Radiotherapy, High-Energy
  • Retrospective Studies
  • Survival Analysis
  • Survival Rate
  • Tongue Neoplasms / pathology*
  • Tongue Neoplasms / therapy